37 million shares bought today at 11 centsApproximately 14 million of those were acquired by the selling house, probably intra house transfers to its other clients .
Cash value here is about $50 million or about 16 cents per share.
An update on the FDA meeting is expected very shortly.
As I said earlier, the clinical trial results seem to be very good with high probability of life extension with a very good safety profile.
What I expect is that the FDA will recommend some minor tests such that efficacy measures and survival induces cf with conventional are clearly defined and incremental.
The market seems to be saying the same thing.
Trading below cash and on the cusp of final approval of a world class drug, such news would see the share price reach former highs